2'-fucosyllactose

1 paper4 findings

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Animals1

Outcomes

Inflammatory cytokines

downin rats1

1 study

2'-fucosyllactose decreases inflammatory cytokines in rats.
“improved intestinal integrity and reduced inflammatory cytokine levels.”
Animalsin ovariectomized rats
2'-Fucosyllactose attenuates estrogen-deficiency-associated bone loss and intestinal dysfunction in ovariectomized rats
Journal of the science of food and agriculture14 Aug 2026

Latest

1 in 12 months

Journal of the Science of Food and Agriculture14 Aug